Last reviewed · How we verify
Placeb
At a glance
| Generic name | Placeb |
|---|---|
| Sponsor | Qianfoshan Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Stratification and Treatment in Early Psychosis Study -ASSIST (PHASE3)
- Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B (PHASE3)
- A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients (PHASE2)
- Caffeine and Resistance Training in Older Adults (NA)
- Efficacy of ASIMOMMY® Compared to Domperidone and Placebo in Increasing Breastfeeding: Randomized Single-Blind Controlled Trial in Indonesia (PHASE2)
- Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft (PHASE4)
- Medical Expulsive Therapy Post-SWL For Renal Stones (NA)
- The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placeb CI brief — competitive landscape report
- Placeb updates RSS · CI watch RSS
- Qianfoshan Hospital portfolio CI